<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Russell 2000 Healthcare - Le Fonti New Pharma Italy</title>
	<atom:link href="https://www.newpharmaitaly.it/tag/russell-2000-healthcare/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/tag/russell-2000-healthcare/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Thu, 07 Mar 2024 16:56:13 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://www.newpharmaitaly.it/wp-content/uploads/2022/12/cropped-favicon-new-pharma-italy-32x32.jpg</url>
	<title>Russell 2000 Healthcare - Le Fonti New Pharma Italy</title>
	<link>https://www.newpharmaitaly.it/tag/russell-2000-healthcare/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Sectoral AM: Analisi e previsioni per il settore Healthcare</title>
		<link>https://www.newpharmaitaly.it/sectoral-am-analisi-e-previsioni-per-il-settore-healthcare/</link>
		
		<dc:creator><![CDATA[Elvis Kondi]]></dc:creator>
		<pubDate>Tue, 31 Jul 2018 15:17:15 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Donald Trump]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medtech]]></category>
		<category><![CDATA[MSCI World Healthcare Index]]></category>
		<category><![CDATA[pharma]]></category>
		<category><![CDATA[Russell 1000 Healthcare]]></category>
		<category><![CDATA[Russell 2000 Healthcare]]></category>
		<guid isPermaLink="false">http://www.newpharmaitaly.it/?p=3006</guid>

					<description><![CDATA[<p>Il settore Healthcare, misurato dall&#8217;MSCI World Healthcare Index, ha sovraperformato complessivamente i mercati, mettendo a segno il +2,8%. Il secondo trimestre del 2018 si è rivelato un altro periodo difficile per i mercati azionari globali, con l&#8217;MSCI AC World Index in rialzo dello +0,5%. Le persistenti preoccupazioni, seppure in calo nel corso del trimestre, sulla [&#8230;]</p>
<p>L'articolo <a href="https://www.newpharmaitaly.it/sectoral-am-analisi-e-previsioni-per-il-settore-healthcare/">Sectoral AM: Analisi e previsioni per il settore Healthcare</a> proviene da <a href="https://www.newpharmaitaly.it">Le Fonti New Pharma Italy</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
